130 related articles for article (PubMed ID: 34069035)
1. Making Sense of a Health Threat: Illness Representations, Coping, and Psychological Distress among
Brand H; Speiser D; Besch L; Roseman J; Kendel F
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34069035
[TBL] [Abstract][Full Text] [Related]
2. Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1/2 Mutation Carriers: a Systematic Review.
Ringwald J; Wochnowski C; Bosse K; Giel KE; Schäffeler N; Zipfel S; Teufel M
J Genet Couns; 2016 Oct; 25(5):880-91. PubMed ID: 27074860
[TBL] [Abstract][Full Text] [Related]
3. Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis.
Metcalfe KA; Price MA; Mansfield C; Hallett DC; Lindeman GJ; Fairchild A; Posner J; Friedman S; Snyder C; ; Lynch HT; Evans DG; Narod SA; Liede A
Br J Cancer; 2020 Jul; 123(2):268-274. PubMed ID: 32393849
[TBL] [Abstract][Full Text] [Related]
4. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
[TBL] [Abstract][Full Text] [Related]
5. Unmet support needs and distress among women with a BRCA1/2 mutation.
Farrelly A; White V; Meiser B; Jefford M; Young MA; Ieropoli S; Winship I; Duffy J
Fam Cancer; 2013 Sep; 12(3):509-18. PubMed ID: 23264090
[TBL] [Abstract][Full Text] [Related]
6. Adaptation of couples living with a high risk of breast/ovarian cancer and the association with risk-reducing surgery.
Shapira R; Turbitt E; Erby LH; Biesecker BB; Klein WMP; Hooker GW
Fam Cancer; 2018 Oct; 17(4):485-493. PubMed ID: 29209897
[TBL] [Abstract][Full Text] [Related]
7. Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.
Lodder LN; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
J Med Genet; 1999 Dec; 36(12):906-13. PubMed ID: 10593998
[TBL] [Abstract][Full Text] [Related]
8. Psychological factors influencing emotional reactions to gestational trophoblastic disease: The role of coping mechanisms and illness perception.
Di Mattei V; Mazzetti M; Perego G; Cugnata F; Brombin C; Bergamini A; Cioffi R; Vasta F; Pella F; Rabaiotti E; Mangili G; Candiani M
Eur J Cancer Care (Engl); 2021 May; 30(3):e13404. PubMed ID: 33459425
[TBL] [Abstract][Full Text] [Related]
9. Distress in couples approached for genetic counseling and BRCA1/2 testing during adjuvant radiotherapy.
Schlich-Bakker KJ; ten Kroode HF; Wárlám Rodenhuis CC; Ausems MG; van den Bout J
Psychooncology; 2009 Sep; 18(9):965-73. PubMed ID: 19140177
[TBL] [Abstract][Full Text] [Related]
10. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
11. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
[TBL] [Abstract][Full Text] [Related]
12. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
[TBL] [Abstract][Full Text] [Related]
13. Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants.
Tercyak KP; Peshkin BN; Streisand R; Lerman C
Psychooncology; 2001; 10(4):336-46. PubMed ID: 11462232
[TBL] [Abstract][Full Text] [Related]
14. Using the common-sense model to understand health outcomes for medically unexplained symptoms: a meta-analysis.
McAndrew LM; Crede M; Maestro K; Slotkin S; Kimber J; Phillips LA
Health Psychol Rev; 2019 Dec; 13(4):427-446. PubMed ID: 30196755
[TBL] [Abstract][Full Text] [Related]
15. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA;
Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481
[TBL] [Abstract][Full Text] [Related]
16. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
Metcalfe K; Lynch HT; Foulkes WD; Tung N; Kim-Sing C; Olopade OI; Eisen A; Rosen B; Snyder C; Gershman S; Sun P; Narod SA
JAMA Oncol; 2015 Jun; 1(3):306-13. PubMed ID: 26181175
[TBL] [Abstract][Full Text] [Related]
17. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
McLaughlin JR; Risch HA; Lubinski J; Moller P; Ghadirian P; Lynch H; Karlan B; Fishman D; Rosen B; Neuhausen SL; Offit K; Kauff N; Domchek S; Tung N; Friedman E; Foulkes W; Sun P; Narod SA;
Lancet Oncol; 2007 Jan; 8(1):26-34. PubMed ID: 17196508
[TBL] [Abstract][Full Text] [Related]
18. Psychological distress related to BRCA testing in ovarian cancer patients.
Bjørnslett M; Dahl AA; Sørebø Ø; Dørum A
Fam Cancer; 2015 Dec; 14(4):495-504. PubMed ID: 25980896
[TBL] [Abstract][Full Text] [Related]
19. Can illness perceptions and coping predict psychological distress amongst allergy sufferers?
Knibb RC; Horton SL
Br J Health Psychol; 2008 Feb; 13(Pt 1):103-19. PubMed ID: 17535490
[TBL] [Abstract][Full Text] [Related]
20. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
van der Kolk DM; de Bock GH; Leegte BK; Schaapveld M; Mourits MJ; de Vries J; van der Hout AH; Oosterwijk JC
Breast Cancer Res Treat; 2010 Dec; 124(3):643-51. PubMed ID: 20204502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
